CNOOC Limited Profile Avatar - Palmy Investing

CNOOC Limited

CNOOC Limited, an investment holding company, explores for, develops, produces, and sells crude oil and natural gas in offshore China, Canada, the United States, the United Kingdom, Nigeria, Argentina, Indonesia, Uganda, Iraq, Brazil, Guyana, Russia, Aus…

Oil & Gas Exploration & Production
HK, Central [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth n.A. n.A.
Leverage & Liquidity 50% Balanced
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q2 Δ in %
EV/EBITDA 23.79 18.09 14.61
Graham Fair Price 0.67 16.92 16.80
PEG inf 0.00 -0.16
Price/Book 21.55 1.44 1.18
Price/Cash Flow -61.85 11.19 -29.34
Prices/Earnings 22.83 6.47 5.27
Price/Sales 19.62 8.98 7.51
Price/FCF -61.85 11.19 -29.34
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q2 Δ in %
Gross Profit Margin 46.47 0.78 0.53
Operating Margin -2.69 0.46 0.47
ROA -1.16 0.04 0.04
ROE 0.06 0.06 -1.04
ROIC 0.05 0.05 3.04
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q2 Δ in %
Debt QOQ 0.00 0.00 0.00
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 0.00 0.00 0.00
EPS QOQ 0.00 0.00 0.00
FCF QOQ 0.00 0.00 0.00
Revenue QOQ 0.00 0.00 0.00
Naive Interpretation member
03 - Financial Growth · Not Interpreted
Fundamentals

Leverage & Liquidity

Metric Q4 Q2 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 10.86 21.52 98.06
Days Sales Outstanding (DSO) 42.35 32.52 -23.21
Inventory Turnover 8.28 4.18 -49.51
Debt/Capitalization 0.15 0.10 -28.29
Quick Ratio 2.14 1.75 -18.14
Naive Interpretation member
04 - Leverage & Liquidity · Balanced
Fundamentals

Per Share Metrics

Metric Q4 Q2 Δ in %
Book Value 14.97 15.16 1.21
Cash 4.79 4.95 3.29
Capex 0.60 0.55 -9.21
Free Cash Flow -0.60 1.94 222.43
Revenue 2.36 2.42 2.83
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q4 Q2 Δ in %
Current Ratio 2.19 1.79 -18.26
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -1.19 -0.91 23.03
Naive Interpretation Member
06 - Financial Health · Weak
End of CEO's Analysis
CIK: 1095595 CUSIP: 126132109 ISIN: US1261321095 LEI: - UEI: -
Secondary Listings